NLRP3 and cancer: Aberrant activation of the NLRP3 inflammasome is associated with the onset and progression of many diseases including metabolic syndrome, type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease, chronic kidney disease, cancer, depression, neurodegenerative and autoimmune diseases, and endometriosis.